Source: Annual Congress 2006 - Difficult tuberculosis cases
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. A. Gorbath (The City of Minsk, Belarus). The forecast of treatment of a tuberculosis of bodies of breath. Eur Respir J 2006; 28: Suppl. 50, 272

Member's Comments

No comment yet.

Related content which might interest you: Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis Source: Eur Respir J 2011; 37: 376 Year: 2011 The value of exhaled breath condensate ‘pH‘ to evaluate the severity of disease and the response to treatment in patients with community acquired pneumonia Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 Experience of the bronchial treatment of tuberculosis of the bronchos in the conditions of the tuberculosis epidemic in Ukraine Source: Annual Congress 2007 - Therapeutic bronchoscopy Year: 2007 Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban Year: 2008 Volatile markers of pulmonary tuberculosis in the breath Source: Annual Congress 2004 - Genetics and immunology of tuberculosis Year: 2004 Extrapulmonary tuberculosis and simultaneous tuberculosis – possible indices for general population‘s health evaluation Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis Year: 2008 Detecting active pulmonary tuberculosis with a breath test using nanomaterial-based sensors Source: Eur Respir J 2014; 43: 1522-1525 Year: 2014 Electronic nose as a surrogate marker of response to treatment of pulmonary tuberculosis (ELNOSUR study) Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 A T-cell-based assay for rapid diagnosis of difficult cases of tuberculosis (TB): smear negative pulmonary and extra-pulmonary TB Source: Eur Respir J 2005; 26: Suppl. 49, 240s Year: 2005 Biomass fuel exposure and pulmonary tuberculosis in Turkey Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II Year: 2008 The rate of tuberculosis infection in closed contacts of smear positive pulmonary tuberculosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 474s Year: 2002 Peculiarities in implementation of national tuberculosis program in patients with smear negative pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 190s Year: 2004 Effect on treatment of giving information about tuberculosis to the tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 644s Year: 2005 Comparison of different sputum examination methods to determine time for discontinuation of respiratory isolation for tuberculosis patients Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II Year: 2008 Velocity of sputum conversion during the treatment of tuberculosis (TB) Source: Eur Respir J 2006; 28: Suppl. 50, 857s Year: 2006 A study of patients with pulmonary tuberculosis and confirmed coexistence of nontuberculous mycobacteria during treatment: Does the use of the additional acid-fast bacilli sputum test lead to shorter hospitalization? Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014 Effectiveness of inhaled hypertonic saline application for sputum induction to improve Mycobacterium tuberculosis identification in patients with pulmonary tuberculosis Source: Virtual Congress 2021 – Challenges and advances in the diagnosis and clinical management of tuberculosis Year: 2021 Response to empirical anti-tuberculosis treatment in patients with sputum smear-negative pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 845s Year: 2006 On abandon of the tuberculosis treatment Source: Eur Respir J 2003; 22: Suppl. 45, 522s Year: 2003 Cough improves earlier than sputum after treatment initiation in hospitalised patients with pulmonary tuberculosis Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020